1. Start
  2. Welcome to Humana
  3. Press
  4. Press releases
  5. Nomination Committee for the 2019 Annual General Meeting

Nomination Committee for the 2019 Annual General Meeting


In February 2016 at an extraordinary General Meeting Humana adopted an instruction regarding the appointment of the Nomination Committee, applicable until the General Meeting resolves otherwise. Pursuant to this instruction the company shall have a Nomination Committee comprising one representative for each of the four principal shareholders in terms of votes, based on the information received from Euroclear Sweden AB on the last banking day in August, as well as the Chairman of the Board (convenor).

The Annual General Meeting of Humana AB will be held on Thursday, May 9, 2019 in Stockholm. 

The Nomination Committee for the Annual General Meeting has now been appointed and comprises the following members:

· Lloyd Perry, representative from Argan Capital (Air Syndication SCA), Chairman of the Nomination Committee
· Alexander Kopp, representative from Incentive AS
· Katarina Hammar, representative from Nordea Funds Ltd
· Sven-Erik Zachrisson, representative from Zirkona AB
· Per Båtelson, Humana’s Chairman of the Board

The Nomination Committee shall prepare proposals for the 2019 Annual General Meeting regarding the Chairman of the Meeting, number of Board members, fees to be paid to each of the Board members, election of Board members and Board Chairman, remuneration to the auditor and election of auditor and, if necessary, proposal for changes in the instruction to the Nomination Committee.

Shareholders who wish to present proposals to the Nomination Committee for the 2019 Annual General Meeting can submit them through email to: arsstamma@humana.se or by post to: Humana AB, AGM, att: Anna Sönne, Warfvinges väg 39, 112 51 Stockholm.

In order for the Nomination Committee to be able to consider submitted proposals in a constructive manner, these should be submitted by 15 January 2019, at the latest.

For more information, please contact:
Anna Sönne, Head of Investor Relations, +46 70-601 48 53, anna.sonne@humana.se

Related files